FeaturedSaudi Arabia

India: Bharat Biotech aims to make 700m doses of vaccine

- Advertisement -

India’s Bharat Biotech is aiming to have a production capacity of about 700 million doses of its COVID-19 vaccine this year, according to a top executive of the biotechnology company.

The vaccine candidate, COVAXIN, received emergency use approval from India’s drugs regulator on Sunday, a move that faced questions from industry experts and opposition lawmakers due to lack of efficacy data.


- Advertisement -

Related Articles

Back to top button